BIOA
BioAge Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.59
+0.95%Margins
Gross margin
99.4%
EBITDA margin
-907.1%
EBIT margin
-1026.3%
Net margin
-912.3%
FCF margin
-850.7%
-25.2%
Return on equity
-23.8%
Return on assets
-28.1%
Return on invested capital
0.03x
Asset turnover
-$87.6M
Cash from operations
$6.94
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026